Page 7 - Tissue Technologies News Today

StockNews.com began coverage on shares of Integra LifeSciences (NASDAQ:IART – Get Rating) in a report released on Thursday. The firm issued a buy rating on the life sciences company’s stock. Several other research firms have also commented on IART. Citigroup lowered their price objective on shares of Integra LifeSciences from $60.00 to $59.00 and set […]

Integra LifeSciences (NASDAQ:IART – Get Rating) and UFP Technologies (NASDAQ:UFPT – Get Rating) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk. Profitability This table compares Integra LifeSciences and UFP Technologies’ net […]

Jennison Associates LLC lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) by 5.6% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 359,315 shares of the life sciences company’s stock after buying an additional 18,950 shares […]

Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) – Stock analysts at Zacks Research dropped their Q2 2023 earnings per share estimates for shares of Integra LifeSciences in a research report issued to clients and investors on Monday, May 8th. Zacks Research analyst R. Anand now forecasts that the life sciences company will post earnings […]

New facility is dedicated to Dr. Richard E. ...

11.05.2023 - New facility is dedicated to Dr. Richard E. Caruso, late company founderPRINCETON, N.J., May 11, 2023 (GLOBE NEWSWIRE) - Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, hosted a ribbon-cutting ...

Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Rating) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 3,180,000 shares, a drop of 9.1% from the March 31st total of 3,500,000 shares. Currently, 4.5% of the company’s shares are sold short. […]

Should You Buy or Sell Integra LifeSciences Stock? Get The Latest IART Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Should You Buy or Sell Integra LifeSciences Stock? Get The Latest IART Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.

Integra LifeSciences (NASDAQ:IART – Get Rating) updated its FY 2023 earnings guidance on Thursday. The company provided earnings per share guidance of $3.43-$3.51 for the period, compared to the consensus earnings per share estimate of $3.48. The company issued revenue guidance of $1.60 billion-$1.62 billion, compared to the consensus revenue estimate of $1.61 billion. Integra […]